Metagenomic Sequencing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Metagenomics is a research field where genomic analysis of microbial DNA from environmental communities is studied. Metagenomic sequencing techniques enable scientists to analyze genes in the given sample. The method allows researchers to assess microbial diversity and identify the presence of microbes in various environments. Steps involved in metagenomics sequencing include DNA extraction, library preparation, sequencing, assembly, annotation, and statistical analysis.

MARKET SCOPE

The "Global Metagenomics sequencing Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Metagenomics sequencing market with detailed market segmentation by product and service, workflow, technology, application and geography. The report provides key statistics on the market status of the leading Metagenomics sequencing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on Product and Service, the global Metagenomics sequencing market is segmented into Reagents and Consumables, Instruments, Services, Analysis and Data Interpretation Solutions.
  
•   Based on Workflow, the market is categorised into Sample Processing and Library Preparation, Sequencing, Data Processing and Analysis.
  
•   Based on Technology, the market is categorised into 16s rRNA Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Metatranscriptomics.
  
•   Based on Application, the market is categorised into Drug Discovery, Ecological and Environmental Applications, Clinical Diagnostics, Soil Microbiome Applications, Industrial Applications, Veterinary Applications, Other Applications.
  

MARKET DYNAMICS

Drivers:

•   Significant applications of metagenomics in various fields.
  
•   Technological advancements in metagenomics sequencings.
  
•   Various initiatives and funding from government and private bodies for large-scale sequencing projects.
  
•   Declining cost of sequencing
  

Restraints:

•   Lack of skilled professionals and requirement of advance, more efficient and robust bioinformatics tools.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Metagenomics sequencing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Metagenomics sequencing market in these regions.

IMPACT OF COVID-19 ON METAGENOMICS SEQUENCING MARKET

The overall impact of COVID-19 pandemic is projected to remain positive for the metagenomics sequencing market. As, throughout the COVID-19 pandemic, clinical diagnostics and testing is a critical component in mitigating the risk of pandemic and its adoption is on a rapid increase with the rise in number of cases, which enables rapid identification and isolation of infected individuals. The majority of this testing is PCR-based, detecting the presence of the SARS-CoV-2 virus; thereby, having a positive impact on the market. Next-generation sequencing (NGS) and whole genome sequencing of the COVID-19 virus is providing metagenomics data of diagnostic test that is combined with clinical data to search for effective treatments.

MARKET PLAYERS

The report covers key developments in the Metagenomics sequencing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Metagenomics sequencing market are anticipated to lucrative growth opportunities in the future with the rising demand for Metagenomics sequencing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Metagenomics sequencing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Illumina, Inc.
  
•   Thermo Fisher Scientific, Inc.
  
•   QIAGEN N.V.
  
•   PerkinElmer
  
•   Oxford Nanopore Technologies Ltd.
  
•   BGI Group
  
•   Macrogen Inc.
  
•   GENEWIZ
  
•   Eurofins Scientific
  
•   Novogene Corporation
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Metagenomic Sequencing Report Scope